glp-1 agonist diarrhea Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus How to manage diarrhea related

These findings highlight the potential clinical importance of achieving and maintaining weight loss after GLP-1-based treatment initiation. Meeting: European Congress on Obesity 2026 (ECO2026) Never miss a breakthrough: Join the SciTechDaily newsletter

Although nausea and reduced food intake can occur with some GLP-1 receptor agonists, many studies showed reduced alcohol and drug-seeking behaviors even when substances were administered intravenously, suggesting the effects go beyond simple appetite suppression

Optimising dietary fibre intake should be gradual and balanced

Comparison of sodium-glucose cotransporter 2 inhibitors vs glucagonlike peptide-1 receptor agonists and incidence of dry eye disease in patients with type 2 diabetes in Taiwan

J med virol

The gradual titration is designed to allow the body to adjust to GLP-1 receptor activation and minimize gastrointestinal side effects during the initial treatment period